Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Geraldine Maro"'
Autor:
Vincent Rives, Patrick Sommerer, Geraldine Maro, Sarah Mangles, Cedric Hermans, Renato Marino, Giuseppe Malcangi, Catherine Lambert
Publikováno v:
Advances in therapy, Vol. 37, no.6, p. 2988-2998 (2020)
Advances in Therapy
Advances in Therapy
Introduction Despite the well-documented benefits of prophylaxis, treatment burden is still a barrier to adherence in patients with haemophilia. An extended half-life fusion protein linking recombinant FIX (rFIX) with human albumin (rIX-FP) has been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2df5d71e09cc1a1147eb6ead35d75481
https://doi.org/10.1007/s12325-020-01300-6
https://doi.org/10.1007/s12325-020-01300-6
Publikováno v:
European Journal of Haematology
Objective To evaluate real‐world outcomes with rVIII‐SingleChain and other commonly used recombinant FVIII (rFVIII) products. Methods Hemophilia treatment centers in Germany (n = 21) contributed patient chart data. Inclusion criteria were prophyl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a86378789ce5db38661f1ccae4bb4a5
https://doi.org/10.1111/ejh.13378
https://doi.org/10.1111/ejh.13378
Publikováno v:
Current medical research and opinion. 36(1)
Objective: An extended half-life factor IX (FIX) fusion protein linking recombinant FIX with recombinant human albumin (rIX-FP), indicated for the treatment of hemophilia B, was approved by the Eur...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2510c4f61de49a51aba5dd5d4b7bf4cf
https://pubmed.ncbi.nlm.nih.gov/31469321
https://pubmed.ncbi.nlm.nih.gov/31469321